Cipla

Cipla Limited has announced that it will acquire a 100% stake in Inzpera Healthsciences for about ₹110.65 crore. Once completed,…

Cipla to distribute and promote Lilly’s tirzepatide as Yurpeak across India at the same price as Mounjaro, expanding access for…

As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging AI across nearly every aspect…

iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core…

Through the agreement, the existing licensees, Aurobindo, Cipla and Viatris, will be able to develop,  manufacture and supply…

Nair to take charge from July 1, 2025; joins Cipla’s senior management with focus on global manufacturing and compliance

Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy…

Cipla secures final USFDA approval for Protein-bound Paclitaxel 100 mg/vial; launch planned in H1 FY26 in the US market

This partnership aims to enhance ophthalmic care by providing treatment for post- operative inflammation and pain in patients…

Ramandeep Singh, Vice President, Life Sciences and Healthcare, India, Clarivate, discusses the latest innovative R&D,…